Home/Tolerance Bio/Holger Russ, PhD

HR

Holger Russ, PhD

Scientific Co-founder

Therapeutic Areas

Oncology Autoimmune Diseases Transplant Medicine Immunodeficiency Allergy

Tolerance Bio Pipeline

Drug	Indication	Phase
iPSC-derived Thymic Organoids	Immune Reconstitution / Oncology (e.g., Melanoma)	Pre-clinical

Leadership Team at Tolerance Bio

Francisco Leon, MD, PhD

Founder and CEO

Chief Financial Officer

Chief Business Officer

Yeh-Chuin Poh, PhD

SVP, Head of Tech Ops

View full Tolerance Bio profile